Effects of an SGLT Inhibitor on the Production, Toxicity, and Elimination of Gut-Derived Uremic Toxins: A Call for Additional Evidence

Sodium–glucose cotransporter (SGLT) inhibitors are a class of oral hypoglycemic agents, which, in recent years, have been shown to improve renal and cardiovascular outcomes in patients with diabetic and non-diabetic chronic kidney disease. There remains considerable debate regarding the potential gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Evenepoel, Pieter, Meijers, Bjorn, Masereeuw, Rosalinde, Lowenstein, Jerome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954461/
https://www.ncbi.nlm.nih.gov/pubmed/35324707
http://dx.doi.org/10.3390/toxins14030210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954461/
https://www.ncbi.nlm.nih.gov/pubmed/35324707
http://dx.doi.org/10.3390/toxins14030210

Ejemplares similares